Medindia

X

FDA Approves Neuropace’s Implantable Neurostimulator for Treatment-Resistant Epilepsy

by Kathy Jones on  November 15, 2013 at 7:34 PM Medical Gadgets   - G J E 4
The US Food and Drug Administration announced that it has approved California-based Neuropace Inc's implantable neurostimulator for reducing the number of seizures in epilepsy patients who have not responded well to medications.
 FDA Approves Neuropace’s Implantable Neurostimulator for Treatment-Resistant Epilepsy
FDA Approves Neuropace’s Implantable Neurostimulator for Treatment-Resistant Epilepsy
Advertisement

Known as the RNS Stimulator, the device can be implanted within the skull under the scalp and is connected to electrodes that are placed where the seizures are suspected to originate within the brain.

Advertisement
Neuropace conducted a randomized trial involving 191 patients over a period of three-months after which it found that the device was able to cut down the number of seizures by 38 percent per month.

"The neurostimulator detects abnormal electrical activity in the brain and responds by delivering electrical stimulation intended to normalize brain activity before the patient experiences seizure symptoms", the director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, Christy Foreman said.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All